Key factors influencing the price of PKDC.US (Precision BioSciences): Clinical Trial Results: Success or failure in gene editing clinical trials for their therapeutic candidates heavily impacts investor confidence and thus, stock price.

Regulatory Milestones: FDA approvals or setbacks for their gene editing therapies significantly move the stock, reflecting the potential for market access.

Partnerships & Collaborations: Agreements with larger pharmaceutical or biotechnology companies can provide funding, validation, and future revenue streams, positively impacting the stock.

Financial Performance: Revenue, expenses, cash burn rate, and overall financial health influence investor sentiment regarding the company's long-term viability.

Market Sentiment: General investor optimism or pessimism towards the biotechnology sector and gene editing technologies can affect PKDC.US.

Competition: The emergence of competing gene editing technologies or therapies can impact the perceived value of Precision BioSciences' platform and products.

Intellectual Property: The strength and breadth of their patent portfolio are crucial for protecting their gene editing technologies and maintaining a competitive advantage.

Management Team: The experience and expertise of the management team, particularly in gene editing and drug development, affect investor confidence.

Macroeconomic Factors: Broader economic conditions, interest rates, and inflation can impact investor risk appetite and valuations across the biotechnology sector.

News & Media Coverage: Positive or negative news articles, scientific publications, and media reports can influence public perception and trading activity.

Dilution: Issuance of new shares to raise capital can dilute existing shareholders' ownership and potentially lower the stock price.

Technological Advancements: Breakthroughs or setbacks in their gene editing platform (ARCUS) affect the perceived effectiveness and competitiveness of their technology.

Analyst Ratings: Recommendations from financial analysts can influence investor decisions and impact the stock price.